Several epidemiologic studies report on the prevalence of Behçet's syndrome (BS) and
demographic and clinical findings in patients from different countries and ethnicities …

Objectives Both innate and adaptive immune responses are reportedly increased in
Behçet's disease (BD), a chronic, relapsing systemic vasculitis lying at the intersection …

During the last decades the efficacy of biologic agents, mainly of anti-TNFs, in controlling the
activity of serious manifestations of Behcet's Disease (BD) has been established. On the …

Initial case series of small number of patients at the beginning of the pandemic reported a
rather guarded prognosis for Behçet's syndrome (BS) patients infected with SARS-CoV-2. In …

Eosinophilic granulomatosis with polyangiitis (EGPA; formerly Churg–Strauss syndrome) is
a rare anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) …

Objective. This study was aimed at assessing the long‐term ocular control of adalimumab
(ADA) in a large real‐world population with noninfectious primary or secondary uveitis …

Behçet Disease is a relapsing and remitting variable vessel vasculitis characterized by
recurrent mucocutaneous ulcers that can involve almost every organ system in the body …

The impressive potential of biologics has been demonstrated in psoriasis, hidradenitis
suppurativa, and urticaria. Numerous biologicals are entering the field for a restricted …

Objectives Lower extremity deep vein thrombosis (LEDVT) is a serious complication of
Behçet's syndrome. Management constitutes mainly of administration of …

In this both narrative and systematic review, we explore the role of TNF-α in the
immunopathogenesis of Behçet's disease (BD) and the effect of treatment with TNF-α …